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N·Acetyl-leukotriene E4 (N-Ac-LTE4) is a recently discovered metabolite of the 
cysteinylleukotrienes (L T). 1 Although N-Ac-L TE4 has been identified so far only in 
the bile, an enterohepatic cycle for L T has been suggested2 that might provide for some 
LT metabolites access to the systemic circulation. The biological significance of 
N-Ac-LTE4 is not known. Experiments conducted in the pig show that N-Ac-LTE4 has 
very weak actions on the cardiovascular and respiratory systems.3 However, the 
formation of N-Ac-LTE4 has not been shown as yet in the pig. Therefore, we have 
decided to examine the effect of N-Ac-LTE4 in the rat, where LTC4/D4/E4 have potent 
cardiovascular effects and N-Ac-LTE4 is a primary metabolite ofthe LT. 
Rats were anesthetized with ketamine-acepromazine. Next, a Doppler ftow probe 
was implanted on the renal (R), mesenteric (M), and abdominal aorta (for hindquarter 
blood flow, HQ), and a PE-50 catheter was placed in the femoral artery for blood 
pressure (BP) monitoring. N-Ac-LTE4 (Merck Frosst) was administered to the 
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FIGURE 1. Authentie recording of the cardiovascular effects of N-Ac-L TE4 in the conscious rat. 
AP = arterial pressure. M, R, and HQ represent the superior mesenteric, renal, and hindquarter 
circulation, respectively. Arrows represent the time of N-Ac-LTE4 injection. Mean arterial 
pressure and heart rate are given as numeratorfdenominator values, respectively. 
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conscious rat (0.1-30 JLg/kg) and blood flow (BF) in the R, M, and HQ regionswas 
continuously recorded, as was the systemic BP and heart rate. 
N·Ac-L TE4 (n = 6) produced only a moderate pressor response (5-15 mmHg). 
However, MBF was reduced in a dose-dependent manner (up to -50% at 30 s.t&/kg), 
along with an increase in the MVR: 300% (30 s.tg/kg). N-Ac·L TE4 bad no effect at all 
on the renal or HQ circulation in the dose range studied (FIGURE 1 ). Comparison of the 
duration of the effect of N·Ac·LTE4 on MBF to that of LTD4 revealed a more 
prolonged effect of N-Ac-LTE4 (FIGURE 2). 
The data presented in this report clearly show that N-Ac-L TE4 is a biologically 
active metabolite of LT. N-Ac-LTE4 bad a preferential effect on the mesenteric 
circulation with virtually no effect on the R and HQ circulation. In this regard, 
N-Ac-LTE4 is more specific than LTD4 or LTE4, which produce significant renal and 
HQ vasoconstriction in comparable doses4 in this same model. 
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FIGURE 2. The areas score ofthe mesenteric 
blood flow response to N-Ac-LTE •. The over-
all effect of N-Ac·LTE4 is significantly larger 
than LTD4 at p < 0.05 (n- 6). 
The effects of N-Ac-LTE4 in the rat are substantially different from those 
described in the pig.3 The significant vasoconstrictor activity of N-Ac-L TE4 in the rat, 
taken tagether with this LT being the primary bile metabolite, and the possible 
enterohepatic recycling of LT suggest that N-Ac-LTE4 might play an important role in 
systemic effects of L T in this species. Furthermore, the possible role of N·Ac- L TE4 in 
mediation of some of the overall LT effects also presents the need to evaluate LT 
antagonists against N-Ac-LTE4 because the failure of some LT antagonists to 
effectively block N-Ac-LTE/ might underlie their limited capacity to prevent or 
reverse L T -mediated pathological processes. 
REFERENCES 
1. DENZLINGER, C., S. RAAP, W. HAGMANN & D. KEPPLER. 1985. Leukotrienes as mediators in 
tissue trauma. Science 230: 330-332. 
FEUERSTEINet al.: N-Ac-LEUKOTRIENE E-4 419 
2. DENZUNGER, C., A. GUHLMAN, W. HAGMANN, P. H. SCHEUBER, F. SCHEYERL & D. 
KEPPLER. 1986. Cysteinyl leukotrienes undergo enterohepatic circulation. Prostaglandin 
Leukotriene Med. 21: 321-322. 
3. FOSTER, A., 8. FITZSIMMONS & G. LETTS. 1986. The synthesis of N-acetyl-leukotriene E4 
and its effects on cardiovascular and respiratory function of the anesthetized pig. 
Prostaglandins 31: 1077-1086. 
4. EJMERL, J., A-L. SIREN & G. FEUERSTEIN. 1986. Systemic and regional hemodynamic 
effects of leukotriene 0 4 and E4 in the conscious rat. Am. J. Physiol. 251: H700-H709. 
